These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 6637481)
1. Effect of antimalarial drugs on human neutrophil chemotaxis in vitro. Kharazmi A; Valerius NH; Høiby N Acta Pathol Microbiol Immunol Scand C; 1983 Aug; 91(4):293-8. PubMed ID: 6637481 [TBL] [Abstract][Full Text] [Related]
2. [Limits of the efficacy of chloroquine and sulfadoxine-pyrimethamine in Northern Abidjan (Cote d'Ivoire): Combined in vivo and in vitro studies]. Djaman J; Abouanou S; Basco L; Koné M Sante; 2004; 14(4):205-9. PubMed ID: 15745869 [TBL] [Abstract][Full Text] [Related]
3. In vitro study assessing the response of plasmodium falciparum malaria to chloroquine, sulfadoxine/pyrimethamine, quinine and mefloquine in Wad Medani District, Sudan. Nour BY; Faragalla IA; Saeed OK; Mohamadani AA Saudi Med J; 2006 Jun; 27(6):808-12. PubMed ID: 16758040 [TBL] [Abstract][Full Text] [Related]
4. The chemotherapy of rodent malaria. IX. Causal prophylaxis. I. A method for demonstrating drug action on exo-erythrocytic stages. Gregory KG; Peters W Ann Trop Med Parasitol; 1970 Mar; 64(1):15-24. PubMed ID: 5485706 [No Abstract] [Full Text] [Related]
5. In vitro sensitivity of Plasmodium falciparum to amodiaquine compared with other major antimalarials in Madagascar. Randrianarivelojosia M; Harisoa JL; Rabarijaona LP; Raharimalala LA; Ranaivo L; Pietra V; Duchemin JB; Rakotomanana F; Robert V; Mauclere P; Ariey F Parassitologia; 2002 Dec; 44(3-4):141-7. PubMed ID: 12701375 [TBL] [Abstract][Full Text] [Related]
6. Depression of human polymorphonuclear leucocyte function by anti-malarial drugs. Ferrante A; Rowan-Kelly B; Seow WK; Thong YH Immunology; 1986 May; 58(1):125-30. PubMed ID: 2423436 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of sulfadoxine-pyrimethamine in chloroquine resistant falciparum malaria in Bombay. Garg MR; Gogtay NJ; Kshirsagar NA J Assoc Physicians India; 1996 Oct; 44(10):683-5. PubMed ID: 9251339 [TBL] [Abstract][Full Text] [Related]
8. [Variability of in vitro activity of proguanil and cycloguanil on erythrocyte stages of Plasmodium falciparum as a function of culture conditions]. Ndounga M; Basco LK; Ringwald P Bull Soc Pathol Exot; 1999 Dec; 92(5):313-6. PubMed ID: 10690466 [TBL] [Abstract][Full Text] [Related]
9. In vivo sensitivity of Plasmodium falciparum to chloroquine, amodiaquine and sulfadoxine-pyrimethamine in western Uganda. Kamugisha J; Kipp W; Burnham G Trop Geogr Med; 1994; 46(6):364-5. PubMed ID: 7892705 [TBL] [Abstract][Full Text] [Related]
10. Quality evaluation of chloroquine, quinine, sulfadoxine-pyrimethamine and proguanil formulations sold on the market in East Congo DR. Atemnkeng MA; Chimanuka B; Plaizier-Vercammen J J Clin Pharm Ther; 2007 Apr; 32(2):123-32. PubMed ID: 17381662 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy of quinine plus sulfadoxine-pyremethamine for the treatment of uncomplicated falciparum malaria in Bangladesh. Thriemer K; Haque R; Wagatsuma Y; Salam MA; Akther S; Attlmayr B; Fukuda M; Schaecher K; Miller RS; Noedl H Am J Trop Med Hyg; 2006 Oct; 75(4):645-9. PubMed ID: 17038687 [TBL] [Abstract][Full Text] [Related]
12. Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea. Genton B; Baea K; Lorry K; Ginny M; Wines B; Alpers MP P N G Med J; 2005; 48(3-4):141-50. PubMed ID: 17212060 [TBL] [Abstract][Full Text] [Related]
13. Diminished Plasmodium falciparum sensitivity to quinine exposure in vitro and in a sequential multi-drug regimen: A preliminary investigation in Guyana, South America. Best Plummer W; Pinto Pereira L Int J Infect Dis; 2008 Nov; 12(6):e27-31. PubMed ID: 18573671 [TBL] [Abstract][Full Text] [Related]
14. Sensitivity to antimalarial drugs by Plasmodium falciparum in Goundry, Oubritenga province, Burkina Faso. Del Nero L; Lamizana L; Pietra V; Nebié I Parassitologia; 1994 Dec; 36(3):287-93. PubMed ID: 7637999 [TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy and safety of chloroquine and alternative antimalarial drugs: a meta-analysis from six African countries. Mengesha T; Makonnen E East Afr Med J; 1999 Jun; 76(6):314-9. PubMed ID: 10750517 [TBL] [Abstract][Full Text] [Related]
16. Health workers perceptions on chloroquine and sulfadoxine/sulfalene pyrimethamine monotherapies: implications for the change to combination therapy of artemether/lumefantrine in Tanzania. Tarimo DS; Malekela DA East Afr J Public Health; 2007 Apr; 4(1):43-6. PubMed ID: 17907761 [TBL] [Abstract][Full Text] [Related]
17. Resistance of Plasmodium falciparum in vivo to 3 days' treatment with quinine and single-dose Fansidar. Al-Yaman F; Genton B; Mokela D; Alpers MP P N G Med J; 1994 Mar; 37(1):54-6. PubMed ID: 7863730 [No Abstract] [Full Text] [Related]
18. Efficacy of a 3-day oral regimen of quinine in an area of northern Nigeria with low-grade resistance of Plasmodium falciparum to chloroquine and sulphadoxine-pyrimethamine. Adagu SI; Okoyeh JN; Lege-Oguntoye L; Ogala WN; Ogunrinde GO; Faji JT; Sani AH J Trop Med Hyg; 1995 Oct; 98(5):296-8. PubMed ID: 7563254 [TBL] [Abstract][Full Text] [Related]
19. [Mechanisms and dynamics of drug resistance in Plasmodium falciparum]. Le Bras J Bull Soc Pathol Exot; 1999; 92(4):236-41. PubMed ID: 10572658 [TBL] [Abstract][Full Text] [Related]
20. Multi-drug resistant malaria in Sri Lanka. Gunasekera DP; Perera DP Ceylon Med J; 1996 Dec; 41(4):170-1. PubMed ID: 9141768 [No Abstract] [Full Text] [Related] [Next] [New Search]